Recent Company News

• 08:45 AM ET Jul 06, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 04:00 AM ET Jul 03, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 04:08 PM ET Jul 30, 2026
  

  Abivax announces completion of its pre-NDA interaction with the FDA for obefazimod (€108.50, 0.00)

• 02:19 PM ET Jul 17, 2026
  

  Abivax re-engages Centerview to hold discussions with large-cap pharma companies -- La Lettre ($135.77, -2.00)

• 03:15 AM ET Jul 16, 2026
  

  Valerio Therapeutics enters exclusive global R&D collaboration with Abivax, worth up to €2.4M upfront, plus future milestones (€0.46, 0.00)

• 02:45 AM ET Jul 03, 2026
  

  StreetAccount Summary - EU equity offerings recap, week of 29-Jun

• 06:25 PM ET Jul 02, 2026
  

  StreetAccount Sector Summary - Healthcare Weekly Recap